Functional Analysis of DNA Damage Repair Factor WDR70 and Its Mutation in Ovarian Cancer

GUO Lian-di, WANG Dan, YANG Fan. et al

Abstract

To analyze the cellular function of the newly discovered DNA damage repair factor WDR70, and investigate the mutation in ovarian cancer to verify if function loss of the WDR70 gene was associated with ovarian cancer. Methods The WDR70 gene was silenced by using siRNA technique or overexpressed its wild and mutation type by with lentivirus and plasmid in hunman cells. The subcellular localization and biochemical function of WDR70 was analyzes by indirect immunofluorescence and immunoblotting. The expression level of WDR70 and the mutations of its cDNA was checked with RT-PCR sequencing for 1 normal ovarian tissue and 16 ovarian cancer specimen. Results We found gene silencing of WDR70 or overexpression of WDR70 mutation type disrupts the phosphorylation level of homologous recombination functional protein RPA32 and the ability of recruitment at DNA damage site of recombinase RAD51, the loss of function of WDR70 also causes the elevation of the chromosome breakage in metaphase. Meanwhile, we also noticed that the existence of multiple mutations in genomic WDR70 in ovarian cancer specimen. Conclusion Our results defined that in vitro system, WDR70 is a DNA damage repair gene, silencing of WDR70 or overexpression of WDR70 mutation type disrupts homologous recombination and chromosomal instability; the frequent mutations of WDR70 gene in genome of ovarian cancer specimens could also lead to DNA repair defeat and gene instability. Consequently WDR70 gene could represent an anti-cancer mechanism for ovarian cancer.

 

Keywords: DNA damage responses, Ovarian cancer, WDR70 

 

Full Text:

PDF


References


SANCAR A, LINDSEYBOI-TZ LA, UNSALKAQMAZ K,et al. Molecular mechanisms of mammalian DMA repair and the DNA damage checkpoints. Annu Rev Biochem. 2004 (73):39-85.

WOOD RD. DNA repair in eukaryotes. Annu Rev Biochem, 1996(65):135-167.

LOMBARD DB, CHUA KF, RAUL M, et al. DNA repair, genome stability, and aging. Cell,2005,120(4):497-512. HELLEDAY T, PETERMANN E, LUNDIN C, et al. DNA repair pathways as targets for cancer therapy. Nat Rev Cancer, 2008,8( 3): 193-204.

WEINERT T. DNA damage and checkpoint pathways: molecular anatomy and interactions with repair. Cell, 1998,94(5):555-558.

GROTH A, ROCHA W, VERREAULT A, et al. Chromatin challenges during DNA replication and repair. Cell,2007,128(4) :721-733.

JEGGO PA, PEARL LH, CARR AM. DNA repair, genome stability and cancer; a historical perspective. Nat Rev Cancer, 2016,16(l):35-42.

ZENG M,REN LF.KEN’LCHI M, et al. CRL4 (Wdr70) regulates H2B monoubiquitination and facilitates Exol- dependent resection. Nat Commun, 2016 ( 7); 11364. doi; 10. 1038/ncommsl 1361.

NIMONKAR AV, JOCHEN G, ER1 K. et al. BLM-DNA2- RPA-MRN and EXOl-BLM-RPA-MRN constitute two DNA end resection machineries for human DNA break repair. Genes Dev.2011,25(4);350-362.

HALAZONETIS TD, GORGOULIS VG, BARTER I. An oncogene-induced DNA damage model for cancer development. Science,2008,319(5868): 1352-1355.

JIRINA B. ZUZANA H. KAREN K. et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature,2005,434(7035) :864-870.

GORGOULIS VG, VASSILIOU LV. KARAKAIDS P. et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature. 2005 . 434 (7035);907-913.

FACKENTHAL JD. OLOPADE OI. Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer.2007,7( 12) :937-948.

BUNTING SF. CALLEN E. WONG N. et al. 53BP1 inhibits homologous recombination in brcal -deficient cells by blocking resection of DNA breaks. Cell.2010. 141 (2); 243- 254.

GRABARZ A, GUIROUILH-BARBAT J. BARASCU A, et al. A role for BLM in double-strand break repair pathway choice; prevention of CtlP/Mrel 1-mediated alternative nonhomologousend-joining. Cell Reports.2013,5( 1) :21-28.


Refbacks

  • There are currently no refbacks.